Head-to-head · Cost-Efficiency Index
Synergy Rx vs EdgeRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Synergy Rx
People who want a genuine brand-name route and maximum clinician access, and will accept getting a quote by inquiry.
Visit Synergy RxEdgeRx
Men who also want adjacent peptide, longevity, and hormone protocols (MICC, sermorelin, NAD+, PT-141) bundled with GLP-1 on one account.
Visit EdgeRxThe verdict
EdgeRx takes it, leading the Cost-Efficiency Index 74 to 72. The best clinical documentation of any newly added row — a named Chief Medical Advisor and a named 503A pharmacy — but it's a men's-only platform, not a fit for every reader. Synergy Rx still earns a C — People who want a genuine brand-name route and maximum clinician access, and will accept getting a quote by inquiry.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs EdgeRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Synergy Rx | EdgeRx |
|---|---|---|
| Cost-Efficiency Index | 72/100 | 74/100 |
| Semaglutide / mo | From $199/mo | $229/mo (once-weekly injectable) |
| Tirzepatide / mo | From $349/mo | $299/mo (once-weekly injectable) |
| Semaglutide / yr (modeled) | $2,388 | $2,748 |
| Tirzepatide / yr (modeled) | $4,188 | $3,588 |
| Coverage | Not disclosed | 46 states — excludes Arkansas, Indiana, Minnesota, South Carolina |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #53 | #55 |
Synergy Rx
72/100Where the value is
- Prescribes FDA-approved brand Wegovy, Ozempic and Mounjaro when clinically appropriate, not compounded only
- Unlimited appointments, unlimited messaging and 24/7 access to a dedicated clinical team
- A $100 welcome credit applied at checkout, and FSA/HSA eligible
The tradeoffs
- Prices are published as bare “Starting at” figures with no billing cycle or term attached, so a full-year cost still cannot be modeled before an inquiry
- At $349/mo tirzepatide sits roughly $100 above the compounded median we track
EdgeRx
74/100Where the value is
- Named Chief Medical Advisor (Dr. John Starke, MD, ABEM board-certified) sets clinical/dosing standards
- Named compounding pharmacy — Strive Pharmacy, a 503A facility operating since 2018
- LegitScript certified, with a specific, named state-exclusion list rather than a vague coverage claim
The tradeoffs
- Men's-only positioning — explicitly not a fit for women readers
- Dr. Starke sets standards but does not personally prescribe; the actual prescribing pool is an unnamed pool of licensed physicians
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.